This article needs to be updated.(August 2021) |
Date | 29 December 2020 | – present
---|---|
Location | Argentina |
Cause | COVID-19 pandemic in Argentina |
Target | Immunisation of Argentines against COVID-19 |
The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. [1] During the first week, 39,599 doses were applied to health professionals. [2]
On 18 February 2021, vaccination on citizens aged over 70 began in the Province of Buenos Aires. Schools, among other sites, were used as temporary vaccination centres. [3]
During the first days of November, the government announced that will acquire during December 2020 and January 2021, 25 million of doses from the Russian vaccine Sputnik V after it would enter phase III. [4] [5] [6] Other vaccines such as the developed by University of Oxford and AstraZeneca, Pfizer, and China were also announced to be acquired eventually. [7]
On 22 December the flight that would bring the first doses of the Sputnik V vaccine to the country left for Moscow, [8] after negotiations began in early December. [9] 300,000 doses arrived on 24 December, [10] with the vaccination campaign beginning on 29 December. [11] The governor of the province of Buenos Aires, Axel Kicillof, was among the first to receive the vaccine. [12] One day later, the AZD1222 vaccine developed by University of Oxford and AstraZeneca was also approved in the country. [13]
On 29 May 2021, health minister Carla Vizzotti met with Cuban president Miguel Díaz-Canel to discuss the possibility of distribution of the still unapproved Cuban-made vaccine SOBERANA 02. [14] [15]
On July 17, 2021, 3.5 million doses of Moderna vaccines arrived at Argentina as part of donation from the United States. [16] Before that, on July 9, 2021, Argentina announced that it had procured 20 million doses from Moderna on its supply deal. [17]
The European Investment Bank is collaborating with the Argentinian government to provide the country with $100 million to assist in the acquisition of COVID-19 vaccinations and to deploy vaccination campaigns. [18]
Vaccine | Approval | Deployment |
---|---|---|
Pfizer–BioNTech | Yes | Yes |
Oxford–AstraZeneca | Yes | Yes |
Sputnik V | Yes | Yes |
Sinopharm BIBP | Yes | Yes |
Moderna | Yes | Yes |
Bharat Biotech | Yes | No |
CanSino | Yes [19] | No |
Vaccine | Type (technology) | Phase I | Phase II | Phase III |
---|---|---|---|---|
CureVac | RNA | Completed | Completed | In progress |
ReiThera | Viral vector | Completed | Completed | In progress |
This article needs to be updated.(August 2021) |
Date | 29 December 2020 | – present
---|---|
Location | Argentina |
Cause | COVID-19 pandemic in Argentina |
Target | Immunisation of Argentines against COVID-19 |
The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. [1] During the first week, 39,599 doses were applied to health professionals. [2]
On 18 February 2021, vaccination on citizens aged over 70 began in the Province of Buenos Aires. Schools, among other sites, were used as temporary vaccination centres. [3]
During the first days of November, the government announced that will acquire during December 2020 and January 2021, 25 million of doses from the Russian vaccine Sputnik V after it would enter phase III. [4] [5] [6] Other vaccines such as the developed by University of Oxford and AstraZeneca, Pfizer, and China were also announced to be acquired eventually. [7]
On 22 December the flight that would bring the first doses of the Sputnik V vaccine to the country left for Moscow, [8] after negotiations began in early December. [9] 300,000 doses arrived on 24 December, [10] with the vaccination campaign beginning on 29 December. [11] The governor of the province of Buenos Aires, Axel Kicillof, was among the first to receive the vaccine. [12] One day later, the AZD1222 vaccine developed by University of Oxford and AstraZeneca was also approved in the country. [13]
On 29 May 2021, health minister Carla Vizzotti met with Cuban president Miguel Díaz-Canel to discuss the possibility of distribution of the still unapproved Cuban-made vaccine SOBERANA 02. [14] [15]
On July 17, 2021, 3.5 million doses of Moderna vaccines arrived at Argentina as part of donation from the United States. [16] Before that, on July 9, 2021, Argentina announced that it had procured 20 million doses from Moderna on its supply deal. [17]
The European Investment Bank is collaborating with the Argentinian government to provide the country with $100 million to assist in the acquisition of COVID-19 vaccinations and to deploy vaccination campaigns. [18]
Vaccine | Approval | Deployment |
---|---|---|
Pfizer–BioNTech | Yes | Yes |
Oxford–AstraZeneca | Yes | Yes |
Sputnik V | Yes | Yes |
Sinopharm BIBP | Yes | Yes |
Moderna | Yes | Yes |
Bharat Biotech | Yes | No |
CanSino | Yes [19] | No |
Vaccine | Type (technology) | Phase I | Phase II | Phase III |
---|---|---|---|---|
CureVac | RNA | Completed | Completed | In progress |
ReiThera | Viral vector | Completed | Completed | In progress |